Paushak [PAUSHAKLTD] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

Paushak Ltd.

BSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Paushak Ltd. wins in 15 metrics, Neogen Chemicals Ltd. wins in 5 metrics, with 0 ties. Paushak Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Paushak Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 33.60 222.22 Paushak Ltd.
Price-to-Book Ratio 2.55 5.46 Paushak Ltd.
Debt-to-Equity Ratio 12.49 141.47 Paushak Ltd.
PEG Ratio -0.56 -3.52 Paushak Ltd.
EV/EBITDA 21.66 42.55 Paushak Ltd.
Profit Margin (TTM) 16.88% 2.41% Paushak Ltd.
Operating Margin (TTM) 13.26% 11.39% Paushak Ltd.
EBITDA Margin (TTM) 13.26% 11.39% Paushak Ltd.
Return on Equity 10.61% 4.41% Paushak Ltd.
Return on Assets (TTM) 8.63% 1.99% Paushak Ltd.
Free Cash Flow (TTM) $-1.23B $-1.22B Neogen Chemicals Ltd.
Dividend Yield 0.77% 0.19% Paushak Ltd.
1-Year Return -22.61% 10.59% Neogen Chemicals Ltd.
Price-to-Sales Ratio (TTM) 5.67 5.56 Neogen Chemicals Ltd.
Enterprise Value $12.87B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 5.96 6.55 Paushak Ltd.
Gross Profit Margin (TTM) 79.59% 47.11% Paushak Ltd.
Revenue per Share (TTM) $88 $310 Neogen Chemicals Ltd.
Earnings per Share (Diluted) $14.78 $7.47 Paushak Ltd.
Beta (Stock Volatility) 0.15 0.22 Paushak Ltd.

Paushak Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

PAUSHAKLTD
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Paushak Ltd.-2.98%12.68%4.50%19.68%-12.31%-15.24%
Neogen Chemicals Ltd.1.10%1.33%11.63%38.07%75.61%60.11%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Paushak Ltd.-22.61%-48.56%-53.36%432.00%5,287.55%2,296.72%
Neogen Chemicals Ltd.10.59%19.04%106.75%609.06%609.06%609.06%

Performance & Financial Health Analysis: Paushak Ltd. vs Neogen Chemicals Ltd.

MetricPAUSHAKLTDNEOGEN
Market Information
Market Cap i₹11.61B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,897170,744
90 Day Avg. Volume i4,258127,390
Last Close₹487.10₹1,903.60
52 Week Range₹343.00 - ₹991.20₹966.70 - ₹1,960.30
% from 52W High-50.86%-2.89%
All-Time High₹12,400.00 (Apr 11, 2022)₹2,420.00 (Dec 09, 2024)
% from All-Time High-96.07%-21.34%
Growth Metrics
Quarterly Revenue Growth-0.01%0.09%
Quarterly Earnings Growth-0.60%-0.63%
Financial Health
Profit Margin (TTM) i0.17%0.02%
Operating Margin (TTM) i0.13%0.11%
Return on Equity (TTM) i0.11%0.04%
Debt to Equity (MRQ) i12.49141.47
Cash & Liquidity
Book Value per Share (MRQ)₹194.82₹303.78
Cash per Share (MRQ)₹3.73₹57.58
Operating Cash Flow (TTM) i₹389.47M₹645.50M
Levered Free Cash Flow (TTM) i₹493.77M₹348.30M
Dividends
Last 12-Month Dividend Yield i0.77%0.19%
Last 12-Month Dividend i₹40.00₹3.00

Valuation & Enterprise Metrics Analysis: Paushak Ltd. vs Neogen Chemicals Ltd.

MetricPAUSHAKLTD (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i33.60222.22
Forward P/E i11.6372.26
PEG Ratio i-0.56-3.52
Price to Sales (TTM) i5.675.56
Price to Book (MRQ) i2.555.46
Market Capitalization
Market Capitalization i₹11.61B₹44.76B
Enterprise Value i₹12.87B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i5.966.55
Enterprise to EBITDA i21.6642.55
Risk & Other Metrics
Beta i0.150.22
Book Value per Share (MRQ) i₹194.82₹303.78

Financial Statements Comparison: Paushak Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPAUSHAKLTD (2025)NEOGEN (2025)
Revenue/Sales i2.10B7.58B
Cost of Goods Sold i568.74M4.44B
COGS % of Revenue i27.1%58.6%
Gross Profit i1.53B3.13B
Gross Margin i72.9%41.4%
Research & Development iN/A11.50M
Operating Income (EBIT) i454.88M1.09B
Operating Margin i21.7%14.4%
EBITDA i647.47M1.31B
EBITDA Margin i30.9%17.3%
Pre-Tax Income i587.72M501.60M
Pre-Tax Income % of Revenue i28.0%6.6%
Income Tax i93.95M153.30M
Income Tax % of Revenue i4.5%2.0%
Net Income (Profit) i493.77M348.30M
Profit Margin i23.6%4.6%

Balance Sheet & Liquidity Metrics

MetricPAUSHAKLTD (2025)NEOGEN (2025)
Cash & Equivalents i142,00049.60M
Total Current Assets i995.83M10.00B
Total Current Assets % of Revenue i47.5%132.0%
Total Current Liabilities i444.39M7.33B
Total Current Liabilities % of Revenue i21.2%96.8%
Long-Term Debt i250.00M1.94B
Long-Term Debt % of Revenue i11.9%25.6%
Total Shareholders Equity i4.65B7.89B
Retained Earnings iN/A2.28B
Retained Earnings % of Revenue i0.0%30.1%
Property, Plant & Equipment i171.74M890.30M

Cash Flow Statement Comparison

MetricPAUSHAKLTD (2025)NEOGEN (2025)
Operating Cash Flow i389.47M645.50M
Operating Cash Flow % of Revenue i18.6%8.5%
Capital Expenditures i-1.60B-3.17B
Free Cash Flow i-1.23B-1.22B
FCF Margin i-58.6%-16.1%
Debt Repayment iN/A-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPAUSHAKLTDNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.66M27.38M
Float Shares i7.01M13.28M
% Held by Insiders i71.59%53.98%
% Held by Institutions i0.00%23.81%
% Held by Public i28.41%22.21%

Dividend Analysis & Yield Comparison: Paushak Ltd. vs Neogen Chemicals Ltd.

MetricPAUSHAKLTDNEOGEN
Last 12-Month Dividend i₹40.00₹3.00
Last 12-Month Dividend Yield i0.77%0.19%
3-Year Avg Annual Dividend i₹23.17₹2.00
3-Year Avg Dividend Yield i0.27%0.11%
3-Year Total Dividends i₹69.50₹6.00
Ex-Dividend DateJul 24, 2025Sep 19, 2025